September 2026
The RNA editing therapies market expands with clinical progress in precision therapeutics, rare disease solutions, and gene-based medicine.
September 2026
The global RNA editing market size was valued at USD 16.91 billion in 2026 and is expected to surpass around USD 27.79 billion by 2035, growing at a CAGR of 5.71% from 2026 to 2035.
July 2026
The global gene editing & mRNA tool kits market is driving advancements in gene therapy, synthetic biology, and molecular diagnostics worldwide
June 2026
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
September 2026
The global alternative fuel vehicle market is projected to hit around USD 1,314.44 billion by 2035 from USD 505.03 billion in 2026 with a CAGR of 11.59%
September 2026
The global complementary and alternative medicine market size is valued at USD 241.70 billion in 2026 and is expected to hit around USD 1,412.89 billion by 2035 with a CAGR of 22.00%.
September 2026
The internal combustion engine market demand is expected to surge around 5,58,977.43 thousand units by 2035 from 2,37,045.81 thousand units in 2025 with a CAGR of 8.96%.
September 2026
The global genome editing market size is evaluated at USD 12.76 billion in 2026 and is projected to worth around USD 48.19 billion by 2035 with a CAGR of 16.01%.
September 2026
The global alternative protein market size was surpassed at USD 19.50 billion in 2026 and is predicted to attain around USD 38.91 billion by 2035 with a CAGR of 8%.
September 2026
The miRNA tools market reached USD 642.07 billion in 2026, with key miRNA tools companies including thermos fisher scientific, agilent technologies, Qiagen, illumine inc, Bio-Rad laboratories inc.
September 2026
The global alternative accommodation market size is projected to hit around USD 1,043.15 billion by 2035 from USD 272.07 billion in 2026, with a solid CAGR of 16.15%.
September 2026
The global oral obesity therapies market size was evaluated at USD 4.70 billion in 2026 and is predicted to hit around USD 9.34 billion by 2035, growing at a CAGR of 7.94%.
September 2026
The global clinical AI model governance market size was evaluated at USD 2.58 billion in 2026 and is predicted to hit around USD 55.00 billion by 2035, growing at a CAGR of 40.46%.
September 2026
The global external ventricular drain market size was valued at USD 8.23 billion in 2026 and is projected to hit around USD 13.47 billion by 2035 with a CAGR of 5.66%.
September 2026
The genetic editing for ASCVD market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
September 2026
The global plastic alternative packaging market size is projected to hit around USD 28.89 billion by 2034 from USD 8.34 billion in 2026, with a CAGR of 16.81%.
September 2026
The U.S. targeted DNA RNA sequencing market size is accounted to hit around USD 27.72 billion by 2035 increasing from USD 5.73 billion in 2026, with a CAGR of 19.17%.
September 2026
The global hydrogen internal combustion engines market size was estimated at USD 24.25 billion in 2026 and is expected to hit around USD 51.76 billion by 2034, growing at a CAGR of 9.94%.
September 2026
The enterprise governance, risk and compliance solutions market size stood at USD 18.24 billion in 2026, with major SAP SE, Oracle Corporation, IBM Corporation, MetricStream Inc., RSA Security LLC companies including enterprise governance, risk and compliance solutions market.
September 2026
The b-cell maturation antigen (BCMA) targeted therapies market size reached USD 6.62 billion in 2026, with leading B-Cell Maturation Antigen (BCMA) Targeted Therapies Market companies including Bristol Myers Squibb, Johnson & Johnson, GSK plc, Amgen Inc., Regeneron Pharmaceuticals, Inc.
September 2026
The AI ethics and governance solutions market reached USD 2.44billion in 2026, featuring leading AI ethics and governance solutions market companies such as IBM Corporation, Microsoft Corporation, Accenture Plc, Google LLC (Alphabet Inc.), SAS Institute Inc.
September 2026
The CAR-T therapies for blood cancers market generated USD 8.09 billion in 2026, with prominent CAR-T therapies for blood cancers market companies including Novartis AG, Gilead Sciences, Inc. (Kite Pharma), Bristol Myers Squibb Company (Celgene/Juno Therapeutics), Johnson & Johnson (Legend Biotech Corporation).
September 2026
The AI in healthcare governance and safety market size stood at USD 2.96 billion in 2026, with major AI in healthcare governance and safety market companies including IBM, Microsoft, Oracle, Google Cloud.
September 2026
The global sternal closure systems market size is estimated at USD 3.13 billion in 2026 and is predicted to surpass around USD 4.77 billion by 2034 with a CAGR of 5.42%.
September 2026
The U.S. radiopharmaceutical therapies market size is estimated to hit around USD 7.70 billion by 2035 increasing from USD 1.92 billion in 2025, with a CAGR of 14.9%%.
August 2026
The autologous stem cell and non-stem cell based therapies market size stood at USD 10.75 billion in 2026, with major autologous stem cell and non-stem cell based therapies market companies including Vericel Corporation, Holostem Terapie Avanzate, Anterogen Co. Ltd., BrainStorm Cell Therapeutics.
July 2026
The dairy alternatives market size was exhibited at USD 34.59billion in 2025 and is predicted to hit around USD 102.74 billion by 2035 with a solid CAGR of 11.50%.
July 2026
The global alternative data market size is calculated at USD 14.16 billion in 2025 and is projected to hit around USD 854.34 billion by 2035 with a CAGR of 50.68%.
July 2026
The global CRISPR-based gene editing market size is accounted to hit around USD 14.96 billion by 2035 increasing from USD 4.46 billion in 2025, with a CAGR of 12.87%.
July 2026
The global RNA interference drug delivery market size is evaluated at USD 118.18 billion in 2025 and is predicted to hit around USD 601.36 billion by 2035, growing at a CAGR of 17.67%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com